Blueshift Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Blueshift Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,364	Closed	-$328K	–	1363
2021 Q3	$328K	Sell	2,364 -12,735	-84%	-$1.59M	0.02%	777
2021 Q2	$1.47M	Buy	+15,099	New	+$1.23M	0.08%	272
2020 Q4	–	Sell	-4,253	Closed	-$276K	–	960
2020 Q3	$276K	Sell	4,253 -4,731	-53%	-$310K	0.04%	477
2020 Q2	$657K	Buy	+8,984	New	+$478K	0.11%	268
2019 Q4	–	Sell	-17,064	Closed	-$712K	–	1139
2019 Q3	$712K	Buy	17,064 +8,970	+111%	+$379K	0.11%	272
2019 Q2	$354K	Sell	8,094 -13,390	-62%	-$755K	0.05%	484
2019 Q1	$1.11M	Buy	21,484 +13,202	+159%	+$570K	0.16%	215
2018 Q4	$306K	Buy	+8,282	New	+$299K	0.06%	484

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blueshift Asset Management's BHVN Position: Q4 2021 in Review

Blueshift Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2021, closing a stake of 2,364 shares — an estimated $328K sold.

Blueshift Asset Management first reported a position in BHVN in Q4 2018 and held it in 8 quarters. The position peaked at $1.47M in Q2 2021. 284 funds tracked by Wall St. Rank hold BHVN as of Q4 2021.

Blueshift Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2021 after selling out during the quarter.
Blueshift Asset Management sold 2,364 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2021, an estimated $328K.
Blueshift Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2018 and held it in 8 quarters.
Blueshift Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.47M in Q2 2021.
284 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.